UPDATED May 20, 2024
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EVER | RON1.36 | 4.2% | 3.4% | RON1.2b | n/a | PE6.3x | n/a | 6.6% | Diversified Financials | ||
LION | RON2.77 | 0.7% | 13.1% | RON1.4b | n/a | PE3.2x | n/a | 4.7% | Diversified Financials | ||
TRANSI | RON0.34 | 4.3% | 12.1% | RON741.2m | n/a | PE3.2x | n/a | 4.4% | Diversified Financials | ||
CMVX | RON106.00 | 1.9% | n/a | RON1.2b | n/a | PE6.5x | n/a | 10.1% | Transportation | ||
ATB | RON1.98 | 3.4% | 223.8% | RON1.3b | n/a | PE13.8x | n/a | 2.3% | Pharmaceuticals & Biotech | ||
SOCP | RON1.69 | -5.1% | 92.0% | RON1.1b | n/a | PE10.8x | n/a | 4.3% | Transportation | ||
BIO | RON0.79 | -3.2% | 21.2% | RON776.5m | n/a | PE11.8x | n/a | 3.9% | Pharmaceuticals & Biotech | ||
SCD | RON3.22 | -1.2% | 59.4% | RON2.2b | n/a | PE10x | n/a | 0% | Pharmaceuticals & Biotech | ||
TTS | RON24.20 | -5.1% | 78.6% | RON1.5b | RON30.40 | PE6.3x | E-22.7% | 4.7% | Transportation | ||
TGN | RON21.50 | 11.7% | 17.6% | RON4.1b | RON21.26 | PE13.4x | E21.8% | 1.6% | Utilities | ||
BVB | RON64.80 | 1.3% | 42.1% | RON521.0m | RON31.00 | PE20.2x | S-18.4% | 2.4% | Diversified Financials | ||
SFG | RON36.40 | 7.4% | 112.2% | RON1.4b | RON31.73 | PE16.3x | E2.7% | 2.9% | Consumer Services |